tbuckley/cabot-search huggingface dataset:
Incorrect Statement.
Journal: JAMA (1997)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Association News.
Journal: JAMA (1901)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Abstract P288: Statin Prescription Patterns at Discharge among Ischemic Stroke Patients. The North Carolina Stroke Care Collaborative
Authors: Anna Kucharska-Newton, Emily O'Brien, Paige Bennett, Wayne Rosamond
Journal: Circulation (2012)

Background: Current American Heart Association/American Stroke Association guidelines recommend in-hospital initiation of statin therapy for stroke patients at the time of hospitalization and at discharge. Nationwide data suggest that despite a favorable trend of increased prescribing of statins at discharge, the overall proportion of stroke patients discharged with statin therapy is significantly below the guideline recommendations. Study aim: To evaluate statin prescribing patterns at discharge for patients hospitalized for ischemic stroke in 56 North Carolina (NC) hospitals participating in the NC Stroke Care Collaborative (NCSCC). Methods: We used data on ischemic stroke admissions in 2008 through 2011 to hospitals affiliated with the NCSCC. Of the total n=39,345 stroke admissions, 23,643 (60%) were admissions for ischemic stroke, as ascertained from ICD-9 discharge codes. Excluded from analysis were stroke admissions that resulted in transfer to another hospital (n=346), patients on observation (n=105) and comfort care only (n=589), patients who died prior to discharge (n=926), those whose hospital visit did not result in admission (n=9), those missing information on statin prescription at discharge (n=3,402), and those with a documented reason for not prescribing statin therapy at discharge (n=675). The final sample size was 19,064 ischemic stroke events. Linear and logistic regression models were used to evaluate factors associated with statin prescribing patterns. Results: Documented statin prescription at discharge varied by age, with the highest proportion of prescriptions registered for stroke patients aged 56-65 years (86%). Statin prescribing at discharge was significantly (p&lt;0.01) lower among patients&lt; 56 years (81%) and those &gt;65 years of age (77%). After adjusting for age, factors associated with low statin prescribing in this population were female gender, small hospital bedsize, academic affiliation of the hospital, and rural location of the hospital. Medical history of dyslipidemia and evidence of lipid lowering medication at admission were positive predictors of statin prescribing at discharge. Conclusions: We observed an age-dependent pattern of statin prescribing at discharge for patients in hospitals affiliated with the NCSCC. The lower proportion of hospitalized ischemic patients over 65 years of age that are discharged on statin therapy compared to those younger is consistent with reports from other studies. The relatively low proportion of patients younger than 56 years with statin prescription at discharge requires further investigation.
Pregnancy after gliosis uteri (endometrii)
Authors: L. M. Nelson
Journal: JAMA (1982)

PROLIFERATION of fetal neural tissue in the endometrium or endocervix occurs rarely. Since the entity was first described by Orsos<sup>1</sup>in 1934, fewer than 30 cases have been verified. Glial tissue in the uterus has been reported using the following various terms to describe what probably represents the same entity:<i>glial polyp</i>,<sup>2</sup><i>glioma of the uterus</i>,<sup>3</sup><i>gliomatosis uteri</i>,<sup>4</sup><i>glial tissue in the uterus</i>,<sup>5</sup>and<i>proliferating</i><i>glia in the endometrium</i>.<sup>6</sup>We prefer Bazala's term<i>gliosis uteri</i>,<sup>7</sup>which describes a benign condition that may persist or recur locally.<sup>2</sup>The condition, as theorized by most authors, probably results from a homograft of fetal glial stroma. We recently had the opportunity to care for a patient with persistent gliosis uteri (endometrii) who wanted to conceive another child. We reviewed the pertinent literature to secure information on fertility subsequent to this problem. To our knowledge, no pregnancies after
PERITONEAL SUPPORTS—(LIGAMENTUM PERITONEI).
Authors: BYRON ROBINSON
Journal: JAMA (1895)

The omentum colicum Halleri is the right lower border of the great omentum. It can be distended with air driven through Winslow's foramen. If one follows the peritoneum from the right kidney upward and outward over the pars descendens duodeni, upward to the anterior part of the transverse colon, it will be noticed that this layer of the peritoneum passes into the anterior layer of the great omentum. This is Haller's omentum and it will extend along the ascending colon for a considerable distance; the point of its lower end may reach the cecum in some embryos which I have examined. This same process of peritoneum which I traced from the right kidney until it was lost in the anterior layer of the great omentum, can also be traced up to the ligamentum hepato-duodenale with which it may blend and form what is known as the ligamentum hepato-colicum. This fold
Clonality in hepatocellular carcinoma: Analysis of methylation pattern of polymorphic X-chromosome?linked phosphoglycerate kinase gene in females
Authors: S KAWAI
Journal: Hepatology (1995)

Analysis of X-chromosome inactivation patterns in women has been used to assess the clonality of various tumors. In this report, we analyzed 27 liver tumors in women, including 18 samples obtained by the performance of ultrasonically guided thin-needle biopsies. By analysis of the heterogeneity of phosphoglycerate kinase gene, 11 of 27 (41%) cases were found to be heterozygous at the gene. Of these informative 11 cases with liver tumors, 7 cases were “large” tumors (>25 mm in diameter) and 4 cases were “small” tumors (<25 mm in diameter). All 7 large tumors showed monoclonal patterns by the phosphoglycerate kinase gene analysis. Of the 4 small tumors, 2 showed monoclonal, and 2 showed polyclonal patterns. The 2 with monoclonal patterns were pathologically diagnosed as hepatocellular carcinoma despite their small sizes (20 mm and 23 mm). Of the two with polyclonal patterns, the smallest one (15 mm) was diagnosed as benign adenomatous hyperplasia, and the other as hepatocellular carcinoma heavily infiltrated by lymphocytes. These data suggest that analysis of the methylation pattern of the phosphoglycerate kinase gene may be helpful on rare occasions in elucidating the nature of liver tumors but must in fact be used in conjunction with histological appearances to avoid errors secondary to inflammatory infiltrates.
The investigation of an unusual asphyxial death in a hospital
Authors: K. Sperry
Journal: JAMA (1986)

ADVANCES in the technology of life support and maintenance during the past several decades have been responsible for the saving of countless lives. A critically ill patient may be surrounded by an overwhelming mass of tubes, wires, and stateof-the-art appurtenances. When a patient's condition deteriorates, life-assist devices and monitors proliferate as all available devices of advanced medical technology are brought to bear in an effort to maintain a life. With the burgeoning of complex equipment there has been an accompanying rise in the number of deaths due to machine malfunction and as complications of long-term indwelling intravascular devices. The potential fatal complications of hemodialysis<sup>1</sup>and Swan-Ganz catheters<sup>2</sup>are particularly well known. Investigation of deaths in such patients requires close scrutiny of all human and mechanical involvement, and an organized, sequential approach to investigation and postmortem examination is optimal.<sup>3</sup>The investigation of iatrogenic deaths related to medical equipment
Metagenomic sequencing in primary sclerosing cholangitis highlights microbial metabolism of essential nutrients and multiple altered species
Authors: Martin Kummen, Louise B. Thingholm, Malte-Christoph Rühlemann, Kristian Holm, Simen H. Hansen, Lucas Moitinho-Silva, Timur Liwinski, Roman Zenouzi, Christopher Storm-Larsen, Marte L. Høyvik, Marius Trøseid, Mette Vesterhus, Matthias Laudes, Wolfgang Lieb, Tom Hemming Karlsen, Corinna Bang, Christoph Schramm, Andre Franke, Johannes R. Hov
Journal: Journal of Hepatology (2020)
Adolescents' compliance with the use of oral contraceptives
Authors: S. J. Emans
Journal: JAMA (1987)

To elucidate the factors that might influence compliance with oral contraceptive use among sexually active adolescents, we undertook a study of 209 unmarried adolescents initiating use of oral contraceptives in three different settings: an inner-city adolescent clinic (I), a birth control clinic in a midsized industrial city (II), and a suburban private practice (III). At the three-month follow-up visit, factors associated with compliance included older age, suburban residence, white race, health care in the suburban private practice, payment status, prior use of contraception, mother's unawareness of oral contraceptives, married parents, older boyfriend, lack of worry about being pregnant, and satisfaction with pill use. Compliance at long-term follow-up (13.5 ± 3.7 months) was additionally associated with educational goals, father's education level, and absence of side effects. Ten pregnancies occurred during the study period among noncompliant site I patients. Inner-city clinic patients were at high risk of noncompliance and unplanned pregnancy. (<i>JAMA</i>1987;257:3377-3381)
Phase IB Study of PKC412, an Oral FLT3 Kinase Inhibitor, in Sequential and Simultaneous Combinations with Daunorubicin and Cytarabine (DA) Induction and High-Dose Cytarabine Consolidation in Newly Diagnosed Patients with AML.
Authors: Richard M. Stone, Thomas Fischer, Ronald Paquette, Gary Schiller, Charles A. Schiffer, Gerhard Ehninger, Jorge Cortes, Hagop Kantarjian, Daniel A. DeAngelo, Richard Yu, Lei Zhang, Pamela S. Cohen, Yanfeng Wang, Penny Phillips, Francis Giles
Journal: Blood (2005)
Wrongful life
Authors: S. M. Schmidt
Journal: JAMA (1983)

DURING the last decade, the number and theories of birth-related legal claims have increased. This increase can be partially attributed to the availability of medical information and genetic and prenatal testing. Prenatal diagnosis through amniocentesis and related procedures during the first trimester of pregnancy has become common, and contraceptive and sterilization techniques have become more readily available. Further,<i>Roe v Wade</i>, 410 US 113 (1973), placed the decision to terminate pregnancy during the first trimester within the woman's constitutional right of privacy. Of all the birth-related legal theories, wrongful life, an action filed on behalf of the infant born with a genetic or other congenital birth defect, has met with the most disapproval. Wrongful life is the child's cause of action. The child alleges that the physician failed to inform and advise the parents adequately concerning foreseeable fetal risks from genetic or other congenital defects. Because of this failure to
Towards global consensus on core outcomes for hidradenitis suppurativa research: an update from the HISTORIC consensus meetings I and II
Authors: L. Thorlacius, A. Garg, J.R. Ingram, B. Villumsen, P. Theut Rii, A.B. Gottlieb, J.F. Merola, R. Dellavalle, C. Ardon, R. Baba, F.G. Bechara, A.D. Cohen, N. Daham, M. Davis, L. Emtestam, P. Fernández-Peñas, M. Filippelli, A. Gibbons, T. Grant, S. Guilbault, S. Gulliver, C. Harris, C. Harvent, K. Houston, J.S. Kirby, L. Matusiak, A. Mehdizadeh, T. Mojica, M. Okun, D. Orgill, L. Pallack, A. Parks-Miller, E.P. Prens, S. Randell, C. Rogers, C.F. Rosen, S.E. Choon, H.H. van der Zee, R. Christensen, G.B.E. Jemec
Journal: British Journal of Dermatology (2018)

Hidradenitis suppurativa (HS) is an uncommon skin condition that causes painful swollen red bumps in the folds of the body (underarms, under breasts, groin, and buttocks). It can be mistaken for bacterial abscess or boils, but HS is not caused by bacteria. HS occurs in about 0.1–1% people in the US and Europe. The authors include people with HS, dermatologists, surgeons, members of the pharmaceutical industry and medical regulators from 13 countries and four continents. This study aimed to find out what clinical trials for HS should measure, such as symptoms (e.g. pain, itch), physical changes (e.g. skin redness or swelling), or impact on people's lives (e.g. quality of life). To do this, the study included two groups: people with HS and healthcare providers (physicians, pharmaceutical industry representatives, and regulatory representatives) and conducted in‐person meetings with presentations and discussions as well as surveys to gather opinions on which measures to include. The result of the meetings, discussions, and surveys showed that at least 70% of the people with HS and healthcare providers recommended that clinical trials include measures of: (1) physical changes due to HS (e.g. redness); (2) changes in the course of HS (e.g. flare‐ups); (3) quality of life changes due to HS specifically; (4) satisfaction (e.g. satisfaction with treatment) ; (5) pain; (6) other symptoms (e.g. itching); and a global rating (i.e. overall rating, considering everything, of the severity of the condition). This work is important because it included many different types of people who contribute to HS treatment, including the people who have HS, develop or regulate treatments, and treat people with HS. More work is coming, and it will focus on final suggestions on what to measure and how to measure it in trials treating HS.
VITAL CAPACITY AND PROGNOSIS
Journal: JAMA (1926)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Structure-specific inhibition by bile acids of adenosine triphosphate?dependent taurocholate transport in rat canalicular membrane vesicles*1
Authors: T NISHIDA
Journal: Hepatology (1995)

The adenosine triphosphate (ATP)-dependent transport system is a major determinant of canalicular bile acid secretion. The system transports bile acids and neither organic cations nor non—bile acid organic anions, such as glucuronides or glutathione adducts. To define the structural specificity of the ATP-dependent system, the authors examined the ability of various bile acids to inhibit ATP-dependent taurocholate transport by rat liver canalicular membrane vesicles. Only bile acids with a negative charge inhibited transport, which was unaffected by side chain length. Conjugated, but not unconjugated, mono- and di-hydroxy bile acids inhibited transport. The presence of 7α- and 12α-hydroxylation also influenced inhibition of ATP-dependent taurocholate transport. Inhibition of transport by bile acids was kinetically competitive. These results suggest that the canalicular ATP-dependent bile acid transport system depends on bile acid side chain charge, conjugation, and hydroxylation.
Archives of Environmental Health, Chicago
Journal: JAMA (1964)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Unilateral leg edema
Authors: L. Kurz
Journal: JAMA (1981)

<h3>In Reply.—</h3> We agree with Dr Kurz that extensive testing is not a substitute for a good history and physical examination. The article stresses the occurrence of lymphoma as a sometimes-overlooked cause of unilateral leg edema. The good clinical judgment of modern house officers, we hope, will make Dr Kurz' fears that it will lead to extensive unnecessary work-ups unfounded.
(5) Melkersson-Rosenthal syndrome
Authors: J. J. Cream, D. Wilson
Journal: British Journal of Dermatology (1983)

Journal Article (5) Melkersson‐Rosenthal syndrome Get access J. J. Cream, J. J. Cream Charing Cross Hospital, London Search for other works by this author on: Oxford Academic Google Scholar D. Wilson D. Wilson Charing Cross Hospital, London Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 109, Issue s24, 1 July 1983, Page 55, https://doi.org/10.1111/j.1365-2133.1983.tb11613.x Published: 01 July 1983
Why Internists Might Want Single-Payer Health Care
Authors: Paul Sorum
Journal: Annals of Internal Medicine (2018)

Letters4 September 2018Why Internists Might Want Single-Payer Health CarePaul Sorum, MD, PhDPaul Sorum, MD, PhDAlbany Medical College, Albany, New York (P.S.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/L18-0247 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:I agree entirely with Dr. Yablon. My argument that the dysfunctional multipayer system promotes physician burnout is intended to complement and reinforce the other compelling reasons for single-payer health care so persuasively presented over the years by Woolhandler and Himmelstein (1, 2) and other members of Physicians for a National Health Program (3).Single-payer health care would particularly reduce the costs of administration and medications (2). In return, it would enable all persons in the United States to access the health care that they need without fear of bankruptcy. To paraphrase Dr. Yablon, it would save lives and ...References1. Woolhandler S, Campbell T, Himmelstein DU. Costs of health care administration in the United States and Canada. N Engl J Med. 2003;349:768-75. [PMID: 12930930] CrossrefMedlineGoogle Scholar2. Woolhandler S, Himmelstein DU. Single-payer reform: the only way to fulfill the president's pledge of more coverage, better benefits, and lower costs. Ann Intern Med. 2017;166:587-8. [PMID: 28241256]. doi:10.7326/M17-0302 LinkGoogle Scholar3. Physicians for a National Health Program. 2018. Accessed at www.pnhp.org on 31 July 2018. Google Scholar4. Morone JA. How to think about “Medicare for all.”. N Engl J Med. 2017;377:2209-11. [PMID: 29069551] doi:10.1056/NEJMp1713510 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: Albany Medical College, Albany, New York (P.S.)Disclosures: The author has disclosed no conflicts of interest. The form can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M17-2678. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoWhy Internists Might Want Single-Payer Health Care Paul Sorum Why Internists Might Want Single-Payer Health Care Brian Yablon Metrics 4 September 2018Volume 169, Issue 5Page: 354KeywordsConflicts of interestDisclosureFearHealth careHealth care policyMedicarePublic policy ePublished: 4 September 2018 Issue Published: 4 September 2018 Copyright & PermissionsCopyright © 2018 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Third World Congress of the World Federation of Associations of Clinical Toxicology and Poison Control Centres and the Twelfth International Congress of the European Association of Poison Control Centres
Journal: JNCI Journal of the National Cancer Institute (1986)

Journal Article Third World Congress of the World Federation of Associations of Clinical Toxicology and Poison Control Centres and the Twelfth International Congress of the European Association of Poison Control Centres Get access JNCI: Journal of the National Cancer Institute, Volume 76, Issue 4, April 1986, Page 780, https://doi.org/10.1093/jnci/76.4.780-a Published: 01 April 1986